City of Hope account plan
Cancer research and treatment
At a glance
City of Hope is a Duarte, California nonprofit cancer care and research system treating 160,000 patients a year, with $5,916,417 thousand of FY2025 revenue.
City of Hope is a California nonprofit public benefit corporation headquartered in Duarte, California, focused on cancer and other life-threatening diseases. It is the parent of the National Medical Center, a Medical Foundation, the Beckman Research Institute, TGen, AccessHope and the former Cancer Treatment Centers of America hospitals in Arizona, Georgia and Illinois. It treats 160,000 patients annually across five major metropolitan areas. In FY2025 (year ended September 30, 2025) total revenues, gains and other support were $5,916,417 thousand and net patient service revenues $4,848,613 thousand. Robert Stone has been CEO since 2014.
Business units
City of Hope National Medical Center
The Duarte main campus hospital, licensed to operate 234 beds, treating primarily cancer and other life-threatening diseases; it belongs to the Obligated Group that carries the system's master-indenture debt.
City of Hope Medical Foundation
Provides teaching, education and research services supporting the Center and the Institute, bills for the City of Hope Medical Group physicians and contracts directly with payors; it owns 50.1% of SCRO.
Beckman Research Institute of the City of Hope
about 14% of FY2025 expenses (research, $810,539 thousand)Owns and operates research facilities on or near the main campus and conducts research with the Center and the Foundation; research grants, contracts and clinical trials brought $306,123 thousand of revenue in FY2025.
COH HoldCo / Cancer Treatment Centers of America hospitals
Three hospitals licensed for a total of 161 beds in Arizona, Georgia and Illinois (Phoenix, Atlanta and Chicago), with their physician groups and outpatient clinics, acquired for $390 million to expand clinical trial enrolment.
Translational Genomics Research Institute (TGen)
A Phoenix-based nonprofit that makes and translates genomic discoveries into advances in human health.
AccessHope
A majority-owned company providing oncology consultative, advisory and support services to employers and payors throughout the United States.
Southern California Radiation Oncology (SCRO)
A for-profit joint venture with Vantage Oncology managing and providing services to radiation therapy centres in Southern California.
Other entities (Stephenson Institute, Orange County property entities)
The Stephenson Global Pancreatic Cancer Research Institute and the entities holding Orange County real estate, including an office building financed by the $43,500 thousand 2024 OC Note.
Strategic priorities
- Ramp up the Orange County campus
- The Irvine cancer specialty hospital opened December 1 as the centrepiece of a $1.5 billion investment on a 72-acre academic research campus; it employs more than 700 people and had to open another floor within a week.
- System-wide clinical trials
- City of Hope runs over 700 cancer-focused clinical trials, deployable across California, Chicago, Atlanta and Phoenix under a single investigator and single budget.
- Faster diagnosis and navigation
- The Orange County goal is to compress diagnosis-to-treatment from weeks to less than a week, and City of Hope books all specialist appointments for the patient.
- Value over cost cutting
- The CEO says cutting costs alone will not deliver the best value, while keeping cost discipline as stewards of patients and donors.
- Earlier detection
- City of Hope aims to develop more screening programmes to detect cancers earlier in younger people.
Investments and deals
- Orange County campus
- A $1.5 billion investment in Irvine, financed in part by a $442,100 thousand 2024 Term Loan; the outpatient centre opened in 2022 and the hospital in December.
- Capital spending
- Additions to property and equipment were $437,449 thousand in FY2025 ($502,334 thousand in FY2024), with $87,802 thousand of commitments for renovations and IT projects.
- Series 2025 bonds and credit line
- $189,140 thousand of Series 2025 Revenue Bonds refunded older bonds, and the line of credit became a $350,000 thousand revolving commitment expiring February 7, 2028.
- Cancer Treatment Centers of America
- Acquired in a $390 million transaction completed in 2022 to build a network of sites for clinical trial enrolment.
Challenges and risks
- Claims denials
- Collections were hurt by claims denials and rejections from third party payers, cutting revenue by $39,185 thousand on prior-period receivables in FY2025.
- Cost growth and lower surplus
- Total expenses rose to $5,721,546 thousand from $5,042,494 thousand, with supplies and pharmaceuticals ($2,101,308 thousand) now above salaries; changes in net assets fell to $198,870 thousand from $498,700 thousand.
- Medicaid cuts
- The CEO expects challenges from Medicaid cuts in the coming years; the article cites a CBO forecast of $1 trillion in reduced Medicaid spending over the next decade.
- Refinancing and labour
- $485,600 thousand of debt matures in fiscal 2027, and four of nine collective bargaining agreements, covering part of the 39% of unionised employees, expire in the following fiscal year.
- Talent and cybersecurity
- Recruiting top physicians is the main challenge named for Orange County, and a 2023 cybersecurity incident led to class actions settled within insurance coverage.
What leadership says
“you're not going to cut your way to providing the best value for patients. You have to reexamine how you provide care.”
“Cancer is the competition, not other healthcare organizations.”
“We really are a single system, and that has helped everything across our national network, to have this oneness among City of Hope.”
Where a supplier can help
- Revenue cycle and denials management
- Tied to the claims denials challenge: tools and services that reduce payer denials and rejections protect collections that cost $39,185 thousand in FY2025.
- Clinical trial operations
- Tied to the system-wide clinical trials priority: running over 700 trials across sites under a single investigator and budget needs trial management, data and enrolment tooling.
- New hospital operations in Irvine
- Tied to the Orange County campus ramp-up: a new, growing acute-care site with more than 700 staff needs equipment, staffing, recruiting and facilities services.
- Supply and pharmacy cost
- Tied to the cost growth challenge: supplies and pharmaceuticals are now the largest expense line, so procurement and pharmacy management offers fit the CEO's stewardship framing.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like City of Hope?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- City of Hope Consolidated Financial Statements, Years Ended September 30, 2025 and 2024 (with Reports of Independent Auditors)
- City of Hope is a California nonprofit public benefit corporation headquartered in Duarte, California, focused on cancer and other life-threatening diseases; it is the parent of a National Medical Center, a Medical Foundation, the Beckman Research Institute, TGen, AccessHope and COH HoldCo (the former Cancer Treatment Centers of America hospitals in Arizona, Georgia and Illinois).
- FY2025 (year ended September 30, 2025): total revenues, gains and other support of $5,916,417 thousand, up from $5,538,699 thousand; net patient service revenues of $4,848,613 thousand, up from $4,156,392 thousand.
- Total expenses rose to $5,721,546 thousand from $5,042,494 thousand; supplies and pharmaceuticals ($2,101,308 thousand) now exceed salaries, wages and benefits ($1,978,532 thousand). Changes in net assets fell to $198,870 thousand from $498,700 thousand.
- Payor mix of net patient service revenues: contracted plans $2,934,668 thousand, Medicare $1,469,860 thousand, Medicaid $282,889 thousand, indemnity/self-pay/other $161,196 thousand.
- Research: research grants, contracts and clinical trials revenue of $306,123 thousand; research expenses of $810,539 thousand; institutionally supported research costs net of grants estimated at $422,610 thousand (unaudited).
- Heavy capital programme: additions to property and equipment of $437,449 thousand in FY2025 ($502,334 thousand in FY2024); construction-in-progress of $714,101 thousand; Orange County campus financed in part by a $442,100 thousand 2024 Term Loan.
- Balance sheet: total assets $9,110,624 thousand, total net assets $5,202,146 thousand, long-term debt $2,530,583 thousand net of current portion, endowment net assets $2,095,865 thousand.
- Risks flagged: claims denials hurting collections (a $39,185 thousand reduction to revenue on prior-period receivables), Medicare/Medicaid regulation, 39% of employees under nine collective bargaining agreements (four expiring in the following fiscal year), and a 2023 cybersecurity incident whose class-action settlement is within insurance coverage.
- Auditor: Ernst & Young LLP, unmodified opinion; statements issued February 25, 2026.
- City of Hope CEO Robert Stone talks about expanding across the country (Chief Healthcare Executive)
- Robert Stone, CEO since 2014 and at City of Hope for 30 years, says he does not support "growth for the sake of growth".
- City of Hope cares for 160,000 patients annually and is in five major metropolitan areas; "86 million people live within a short drive to City of Hope."
- The new Orange County cancer specialty hospital, opened in December, is the centrepiece of a $1.5 billion investment on a 72-acre academic research campus in Irvine; demand forced it to open another floor within a week.
- The $390 million acquisition of Cancer Treatment Centers of America was driven by clinical trials: a network of sites with different populations to enrol patients faster.
- The system spent four years building physician and support infrastructure, tumor boards and disease team structures so that expertise "isn't bounded by geography".
- Patient navigation: City of Hope books all specialist appointments for the patient rather than leaving it to them.
- As many cut costs, City of Hope CEO focuses on value (Chief Healthcare Executive)
- Robert Stone argues "you're not going to cut your way to providing the best value for patients. You have to reexamine how you provide care."
- He insists City of Hope does focus on cost: "We have an obligation to be good stewards to our patients, good stewards to our donors."
- Medicaid cuts are a coming challenge; the article cites a CBO forecast of $1 trillion in reduced Medicaid spending over the next decade.
- "Philanthropy is a huge part of City of Hope... It funds so much for us today."
- Value is defined by patients through survival and quality of life; small co-pay increases make people defer treatment: "in cancer, 'wait' is a four-letter word."
- City of Hope engages in policy: coalitions in California and Illinois for patients' "Bill of Rights", and the California Cancer Care Equity Act signed in 2022.
- City of Hope aims to 'reestablish the standard of care' (Chief Healthcare Executive)
- Dr. Ed Kim, physician-in-chief of City of Hope Orange County and system director of its National Clinical Trials Network, spoke before the Irvine cancer specialty hospital opened on December 1.
- The hospital employs more than 700 people, including an additional 50 physicians, and connects to the Lennar Foundation Cancer Center outpatient complex.
- Goal: compress diagnosis-to-treatment from weeks to "less than a week" on the Orange County campus.
- City of Hope runs over 700 cancer-focused clinical trials, deployable across California sites and the Chicago, Atlanta and Phoenix centres under a single investigator and single budget.
- Outpatient demand in Orange County since 2022 "has been off the charts"; recruiting top talent remains the main challenge.
- Priority on screening programmes to catch cancers earlier in younger people.
Questions about City of Hope
What does City of Hope do?
It is a nonprofit system providing cancer care, research and education, with its main campus in Duarte, California, a new hospital in Irvine and cancer centres in Phoenix, Atlanta and Chicago.
What is City of Hope's revenue?
FY2025 total revenues, gains and other support were $5,916,417 thousand (year ended September 30, 2025), including net patient service revenues of $4,848,613 thousand.
What is City of Hope's strategy?
Expand access across five metropolitan areas, run clinical trials as a single system, speed diagnosis and navigation, and redesign care for value rather than cut costs alone.
Who leads City of Hope?
Robert Stone has been CEO since 2014; Dr. Ed Kim is physician-in-chief of City of Hope Orange County.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)